Skip to main content
International Journal of Nanomedicine logoLink to International Journal of Nanomedicine
. 2021 Sep 24;16:6531–6533. doi: 10.2147/IJN.S340387

Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway [Corrigendum]

PMCID: PMC8478669  PMID: 34602815

Duan L, Zuo J, Zhang F, et al. Int J Nanomedicine. 2020;15:3605–3620.

The authors have advised Figure 9 on page 3618 is incorrect. An error was made during the preparation of images for part 9C. The correct Figure 9 is shown below.

Figure 9.

Figure 9

Expression levels of apoptosis proteins. (A) In the different treatment groups, the p-Akt Bcl-2, and Bad caspase-3 protein expression levels were examined by Western blotting. (B) In the different treatment groups, the Bcl-2, Bad, and caspase-3 mRNA expression levels were examined by RT-PCR. Bar represents the SD, ***P <0.001, *P < 0.05, vs the GC group. (C) The immunofluorescence indicated the expression level of p-Akt, Bcl-2, Bad, and caspase-3 in the bone tissue from the different treatment groups (third month). Scale bar: 200 μm.

The authors apologise for this error.


Articles from International Journal of Nanomedicine are provided here courtesy of Dove Press

RESOURCES